GARIN6
gene geneOn this page
Also known as MGC39520
Summary
GARIN6 (golgi associated RAB2 interactor family member 6, HGNC:28594) is a protein-coding gene on chromosome 12q23.1, encoding Golgi-associated RAB2 interactor protein 6 (Q8NEG0).
At a glance
- Clinical variants (ClinVar): 2 total
- MANE Select transcript:
NM_153364
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:28594 |
| Approved symbol | GARIN6 |
| Name | golgi associated RAB2 interactor family member 6 |
| Location | 12q23.1 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | MGC39520 |
| Ensembl gene | ENSG00000180219 |
| Ensembl biotype | protein_coding |
| Entrez | 196472 |
Gene structure
Transcript identifiers
Ensembl transcripts: 1 — 1 protein_coding
ENST00000324341
RefSeq mRNA: 1 — MANE Select: NM_153364
NM_153364
CCDS: CCDS9072
Canonical transcript exons
ENST00000324341 — 2 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001227163 | 99649288 | 99650114 |
| ENSE00001291290 | 99647753 | 99648789 |
Expression profiles
Bgee: expression breadth broad, 16 present calls, max score 95.55.
FANTOM5 (CAGE): breadth tissue_specific, TPM avg 0.0531 / max 41.5532, expressed in 3 samples.
FANTOM5 promoters (1 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 127558 | 0.0531 | 3 |
Top tissues by expression
215 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| sperm | CL:0000019 | 95.55 | gold quality |
| right testis | UBERON:0004534 | 88.29 | gold quality |
| left testis | UBERON:0004533 | 87.61 | gold quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 86.10 | gold quality |
| testis | UBERON:0000473 | 84.74 | gold quality |
| adult organism | UBERON:0007023 | 67.74 | gold quality |
| endothelial cell | CL:0000115 | 59.75 | gold quality |
| epithelium of nasopharynx | UBERON:0001951 | 57.04 | gold quality |
| esophagus squamous epithelium | UBERON:0006920 | 55.94 | gold quality |
| mammary duct | UBERON:0001765 | 53.95 | gold quality |
| oocyte | CL:0000023 | 52.60 | gold quality |
| cerebellar vermis | UBERON:0004720 | 52.56 | gold quality |
| cardia of stomach | UBERON:0001162 | 50.42 | gold quality |
| nasal cavity epithelium | UBERON:0005384 | 48.71 | gold quality |
| Brodmann (1909) area 46 | UBERON:0006483 | 48.01 | gold quality |
| colonic epithelium | UBERON:0000397 | 47.29 | gold quality |
| thymus | UBERON:0002370 | 46.73 | gold quality |
| buccal mucosa cell | CL:0002336 | 45.83 | gold quality |
| vastus lateralis | UBERON:0001379 | 44.35 | gold quality |
| amniotic fluid | UBERON:0000173 | 44.27 | gold quality |
| quadriceps femoris | UBERON:0001377 | 44.24 | gold quality |
| skeletal muscle tissue of rectus abdominis | UBERON:0004511 | 43.37 | gold quality |
| pharyngeal mucosa | UBERON:0000355 | 43.05 | gold quality |
| secondary oocyte | CL:0000655 | 42.57 | gold quality |
| germinal epithelium of ovary | UBERON:0001304 | 42.30 | gold quality |
| visceral pleura | UBERON:0002401 | 42.23 | gold quality |
| superficial temporal artery | UBERON:0001614 | 41.33 | gold quality |
| palpebral conjunctiva | UBERON:0001812 | 41.10 | gold quality |
| mucosa of paranasal sinus | UBERON:0005030 | 40.98 | gold quality |
| jejunal mucosa | UBERON:0000399 | 40.59 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 1.79 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
43 targeting GARIN6, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-3134 | 100.00 | 66.43 | 777 |
| HSA-MIR-4776-3P | 100.00 | 68.73 | 1340 |
| HSA-MIR-767-5P | 99.95 | 70.85 | 993 |
| HSA-MIR-6780A-5P | 99.88 | 66.69 | 2776 |
| HSA-MIR-10395-5P | 99.86 | 67.35 | 676 |
| HSA-MIR-1273H-5P | 99.77 | 66.32 | 2471 |
| HSA-MIR-378G | 99.71 | 64.90 | 1106 |
| HSA-MIR-30B-3P | 99.70 | 65.76 | 2325 |
| HSA-MIR-3689A-3P | 99.70 | 65.73 | 2306 |
| HSA-MIR-3689B-3P | 99.70 | 65.71 | 2311 |
| HSA-MIR-3689C | 99.70 | 65.71 | 2311 |
| HSA-MIR-6779-5P | 99.70 | 65.76 | 2363 |
| HSA-MIR-6887-3P | 99.66 | 67.83 | 1778 |
| HSA-MIR-3158-5P | 99.65 | 67.51 | 1763 |
| HSA-MIR-10394-5P | 99.65 | 66.83 | 1852 |
| HSA-MIR-6715B-5P | 99.64 | 69.63 | 1420 |
| HSA-MIR-1290 | 99.59 | 69.90 | 2079 |
| HSA-MIR-4269 | 99.55 | 69.89 | 1373 |
| HSA-MIR-12132 | 99.47 | 68.90 | 1341 |
| HSA-MIR-6722-3P | 99.45 | 67.62 | 1919 |
| HSA-MIR-5580-5P | 99.38 | 66.96 | 1139 |
| HSA-MIR-329-5P | 99.27 | 68.11 | 1597 |
| HSA-MIR-6878-3P | 99.24 | 64.23 | 920 |
| HSA-MIR-1909-3P | 99.03 | 66.56 | 1662 |
| HSA-MIR-5590-5P | 98.81 | 68.78 | 969 |
| HSA-MIR-655-5P | 98.74 | 65.93 | 888 |
| HSA-MIR-1246 | 98.54 | 66.21 | 959 |
| HSA-MIR-7156-3P | 98.25 | 67.66 | 859 |
| HSA-MIR-1233-5P | 98.19 | 66.71 | 1201 |
| HSA-MIR-6778-5P | 98.19 | 66.59 | 1239 |
Cross-species orthologs
0 orthologs
Paralogs (7): GARIN1B (ENSG00000135248), GARIN5A (ENSG00000142530), GARIN4 (ENSG00000162771), GARIN3 (ENSG00000170613), GARIN2 (ENSG00000172717), GARIN5B (ENSG00000180043), GARIN1A (ENSG00000205085)
Protein
Protein identifiers
Golgi-associated RAB2 interactor protein 6 — Q8NEG0 (reviewed: Q8NEG0)
All UniProt accessions (1): Q8NEG0
UniProt curated annotations — full annotation on UniProt →
Similarity. Belongs to the GARIN family.
RefSeq proteins (1): NP_699195* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR022168 | GARIL-like_Rab2B-bd | Domain |
Pfam: PF12480
UniProt features (4 total): sequence variant 2, chain 1, sequence conflict 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q8NEG0-F1 | 70.95 | 0.43 |
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 23 (showing top):
WTGAAAT_UNKNOWN, GATA1_03, chr12q23, MARTENS_TRETINOIN_RESPONSE_UP, MIR1290, MIR3158_5P, MIR6715B_5P, MIR509_5P, MIR509_3_5P, MIR4776_3P, MIR6778_5P, MIR1233_5P, MIR2278, MIR4468, MIR10395_5P
GO Biological Process (0):
GO Molecular Function (1): protein binding (GO:0005515)
GO Cellular Component (0):
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| binding | 1 |
Protein interactions and networks
STRING
170 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| GARIN6 | ZNF438 | Q7Z4V0 | 480 |
| GARIN6 | SUSD1 | Q6UWL2 | 479 |
| GARIN6 | ZNF8 | P17098 | 467 |
| GARIN6 | CCDC91 | Q7Z6B0 | 418 |
| GARIN6 | TAF1C | Q15572 | 379 |
| GARIN6 | TTC23L | Q6PF05 | 360 |
| GARIN6 | ANKS1B | Q7Z6G8 | 336 |
| GARIN6 | ADHFE1 | Q8IWW8 | 336 |
| GARIN6 | PARD3B | Q8TEW8 | 327 |
| GARIN6 | KIF21B | O75037 | 318 |
| GARIN6 | BRK1 | Q8WUW1 | 310 |
| GARIN6 | ZNF605 | Q86T29 | 304 |
| GARIN6 | ZNF615 | Q8N8J6 | 293 |
| GARIN6 | SCTR | P47872 | 277 |
| GARIN6 | PTP4A3 | O75365 | 270 |
| GARIN6 | FGL1 | Q08830 | 270 |
IntAct
192 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| RAB2A | GARIN6 | psi-mi:“MI:0915”(physical association) | 0.780 |
| GARIN6 | RAB2A | psi-mi:“MI:0915”(physical association) | 0.780 |
| KRT31 | GARIN6 | psi-mi:“MI:0915”(physical association) | 0.720 |
| GARIN6 | RAB2B | psi-mi:“MI:0915”(physical association) | 0.720 |
| RAB2B | GARIN6 | psi-mi:“MI:0915”(physical association) | 0.720 |
| GARIN6 | KRT31 | psi-mi:“MI:0915”(physical association) | 0.720 |
| FHL3 | GARIN6 | psi-mi:“MI:0915”(physical association) | 0.560 |
| GARIN6 | KRT40 | psi-mi:“MI:0915”(physical association) | 0.560 |
| GARIN6 | NOTCH2NLA | psi-mi:“MI:0915”(physical association) | 0.560 |
| GARIN6 | BANP | psi-mi:“MI:0915”(physical association) | 0.560 |
| GARIN6 | FHL3 | psi-mi:“MI:0915”(physical association) | 0.560 |
| KRT40 | GARIN6 | psi-mi:“MI:0915”(physical association) | 0.560 |
| BANP | GARIN6 | psi-mi:“MI:0915”(physical association) | 0.560 |
| NOTCH2NLA | GARIN6 | psi-mi:“MI:0915”(physical association) | 0.560 |
| GARIN6 | RAB14 | psi-mi:“MI:0915”(physical association) | 0.560 |
| KRT34 | GARIN6 | psi-mi:“MI:0915”(physical association) | 0.560 |
| RAB4B | GARIN6 | psi-mi:“MI:0915”(physical association) | 0.560 |
BioGRID (26): FAM71C (Two-hybrid), FAM71C (Two-hybrid), FAM71C (Two-hybrid), FAM71C (Two-hybrid), FAM71C (Two-hybrid), FAM71C (Two-hybrid), NOTCH2NL (Two-hybrid), FAM71C (Two-hybrid), FAM71C (Two-hybrid), FAM71C (Two-hybrid), FAM71C (Two-hybrid), FAM71C (Two-hybrid), FAM71C (Two-hybrid), FAM71C (Two-hybrid), FAM71C (Two-hybrid)
ESM2 similar proteins: A0A1L8HTT5, A4IIM9, A6NFN9, A9ZLX4, D3YYM4, F1MN90, M0R2J8, O15259, O54828, O60543, O70302, O70303, O75916, P49805, P56198, Q3B7M3, Q3T191, Q3U827, Q4R323, Q4R899, Q4VXA5, Q5JV73, Q5SUS0, Q5SYB0, Q5XI33, Q5XX13, Q61137, Q6AY22, Q6P9P8, Q6ZPF3, Q7TNY7, Q7TP54, Q7TP65, Q80U16, Q80VH0, Q8BLA1, Q8C0W1, Q8K3I4, Q8N2C3, Q8N9Z9
Diamond homologs: A1L3C1, B2RXB0, D3YV92, Q2KIP3, Q2YDE8, Q32L49, Q3UZD7, Q4R323, Q5STT6, Q66H38, Q68FV5, Q6IPT2, Q6NXP2, Q8IYT1, Q8N5Q1, Q8N9W8, Q8NEG0, Q8TC56, Q95K21, Q95K27, Q96KD3, Q5RJN7
SIGNOR signaling
0 interactions.
Enriched among interaction partners
Reactome pathways and GO biological processes over-represented among this gene’s 96 IntAct physical interaction partners (hypergeometric vs the genome-wide background, BH-FDR, gene-set size 15–500, ranked by fold). A functional readout of the neighbourhood — distinct from this gene’s own memberships above, and biased toward well-studied / hub proteins, so read it as themes rather than proof.
Reactome pathways:
| Pathway | Partners | Fold | FDR |
|---|---|---|---|
| Ras activation upon Ca2+ influx through NMDA receptor | 5 | 42.0× | 5e-06 |
| Unblocking of NMDA receptors, glutamate binding and activation | 5 | 40.0× | 5e-06 |
| Negative regulation of NMDA receptor-mediated neuronal transmission | 5 | 40.0× | 5e-06 |
| Long-term potentiation | 5 | 35.0× | 8e-06 |
| Assembly and cell surface presentation of NMDA receptors | 9 | 33.6× | 5e-10 |
| Neurexins and neuroligins | 10 | 29.0× | 3e-10 |
| Protein-protein interactions at synapses | 7 | 27.3× | 4e-07 |
| RAB geranylgeranylation | 5 | 12.7× | 8e-04 |
GO biological processes:
| GO term | Partners | Fold | FDR |
|---|---|---|---|
| establishment or maintenance of epithelial cell apical/basal polarity | 11 | 71.0× | 8e-16 |
| protein localization to synapse | 6 | 51.1× | 2e-07 |
| receptor clustering | 7 | 48.5× | 2e-08 |
| regulation of postsynaptic membrane neurotransmitter receptor levels | 6 | 33.0× | 2e-06 |
| cell-cell adhesion | 10 | 11.3× | 2e-06 |
| protein-containing complex assembly | 8 | 10.1× | 6e-05 |
| Golgi organization | 6 | 8.9× | 1e-03 |
| actin cytoskeleton organization | 7 | 6.2× | 3e-03 |
Disease & clinical
Clinical variants and AI predictions
ClinVar
2 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 2 |
| Likely benign | 0 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
124 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 12:99648769:G:GT | donor_gain | 0.9900 |
| 12:99648787:GTG:G | donor_gain | 0.9900 |
| 12:99648790:GT:G | donor_loss | 0.9900 |
| 12:99648791:T:G | donor_loss | 0.9900 |
| 12:99648792:GA:G | donor_loss | 0.9900 |
| 12:99648790:G:GG | donor_gain | 0.9800 |
| 12:99648793:AG:A | donor_loss | 0.9800 |
| 12:99649286:AG:A | acceptor_gain | 0.9300 |
| 12:99649287:GG:G | acceptor_gain | 0.9300 |
| 12:99649287:GGGAT:G | acceptor_gain | 0.9300 |
| 12:99649282:CCCTA:C | acceptor_loss | 0.9200 |
| 12:99649283:CCTA:C | acceptor_loss | 0.9200 |
| 12:99649284:CTAG:C | acceptor_loss | 0.9200 |
| 12:99649285:TAG:T | acceptor_loss | 0.9200 |
| 12:99649287:G:A | acceptor_loss | 0.9200 |
| 12:99648719:A:AG | donor_gain | 0.9000 |
| 12:99649271:ATTT:A | acceptor_loss | 0.8900 |
| 12:99649286:A:AG | acceptor_gain | 0.8600 |
| 12:99649287:G:GG | acceptor_gain | 0.8600 |
| 12:99648785:CAGTG:C | donor_gain | 0.8500 |
| 12:99648788:TG:T | donor_gain | 0.8500 |
| 12:99648789:GG:G | donor_gain | 0.8500 |
| 12:99649274:T:TA | acceptor_loss | 0.8500 |
| 12:99649286:AGG:A | acceptor_gain | 0.8400 |
| 12:99649287:GGG:G | acceptor_gain | 0.8400 |
| 12:99648769:G:T | donor_gain | 0.8300 |
| 12:99649272:T:G | acceptor_loss | 0.8300 |
| 12:99648786:AGTG:A | donor_gain | 0.7700 |
| 12:99648787:GTGG:G | donor_gain | 0.7700 |
| 12:99648788:TGGT:T | donor_gain | 0.7700 |
AlphaMissense
1602 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 12:99648322:T:C | F50L | 0.994 |
| 12:99648324:T:A | F50L | 0.994 |
| 12:99648324:T:G | F50L | 0.994 |
| 12:99648323:T:C | F50S | 0.990 |
| 12:99648616:T:C | F148L | 0.986 |
| 12:99648618:T:A | F148L | 0.986 |
| 12:99648618:T:G | F148L | 0.986 |
| 12:99648661:T:C | F163L | 0.986 |
| 12:99648663:T:A | F163L | 0.986 |
| 12:99648663:T:G | F163L | 0.986 |
| 12:99648670:T:A | W166R | 0.985 |
| 12:99648670:T:C | W166R | 0.985 |
| 12:99648672:G:C | W166C | 0.985 |
| 12:99648672:G:T | W166C | 0.985 |
| 12:99648316:A:C | S48R | 0.984 |
| 12:99648318:C:A | S48R | 0.984 |
| 12:99648318:C:G | S48R | 0.984 |
| 12:99648422:C:A | P83H | 0.982 |
| 12:99648235:T:C | F21L | 0.978 |
| 12:99648237:T:A | F21L | 0.978 |
| 12:99648237:T:G | F21L | 0.978 |
| 12:99648293:T:C | F40S | 0.976 |
| 12:99648593:T:C | L140P | 0.976 |
| 12:99648623:T:C | L150P | 0.975 |
| 12:99648584:A:C | Q137P | 0.974 |
| 12:99648395:T:A | V74D | 0.973 |
| 12:99648421:C:T | P83S | 0.973 |
| 12:99648434:T:A | L87Q | 0.971 |
| 12:99648323:T:G | F50C | 0.970 |
| 12:99648671:G:C | W166S | 0.970 |
dbSNP variants (sampled 300 via entrez): RS1000161240 (12:99647144 C>T), RS1001030962 (12:99647208 T>C), RS1002042865 (12:99646227 A>G), RS1002279155 (12:99647897 G>C), RS1002289104 (12:99647715 T>A,C,G), RS1003616845 (12:99650500 CCA>C), RS1003965546 (12:99649151 A>G), RS1004396521 (12:99649743 G>A), RS1004786456 (12:99650076 AT>A), RS1005507308 (12:99649569 G>A), RS1005960365 (12:99648859 C>T), RS1005968545 (12:99648635 C>G,T), RS1006508574 (12:99648034 A>T), RS1006789488 (12:99647760 G>C), RS1007509746 (12:99646586 G>A)
Disease associations
OMIM: gene `` | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
0 associations (top):
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
5 total (human), top 5 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| CGP 52608 | affects binding, increases reaction | 1 |
| Acetaminophen | increases expression | 1 |
| Benzo(a)pyrene | affects methylation, increases methylation | 1 |
| Valproic Acid | increases methylation | 1 |
| Cadmium Chloride | increases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.